North Carolina Law Review

University of North Carolina School of Law

160 Ridge Road

Chapel Hill, NC 27514

Patenting and Protecting Personalized Medicine Innovation Post-Mayo, Myriad, and Limelight

January 17, 2017

95 N.C. L. Rev. 493 (2017) 


This Comment argues that, despite the recent subject matter eligibility guidelines provided by the USPTO and in light of the infringement analysis framework set forth in Limelight III, only careful patent drafting with respect to what, specifically, is claimed and how multiple actors interact will ensure that claims directed to personalized medicine innovations are both eligible and protected. 



Please reload